These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9534100

  • 1. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
    Gustafsson F, Køber L, Torp-Pedersen C, Per Hildebrandt.
    J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
    [Abstract] [Full Text] [Related]

  • 2. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
    N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event.
    Gustafsson F, Torp-Pedersen C, Køber L, Hildebrandt P.
    J Hypertens; 1997 Jul 21; 15(7):793-8. PubMed ID: 9222948
    [Abstract] [Full Text] [Related]

  • 4. [The significance of trandelapril for mortality after AMI in patients with reduced left ventricular function. TRACE Study Group].
    Køber L, Torp-Pedersen CT, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J.
    Ugeskr Laeger; 1997 Mar 10; 159(11):1616-22. PubMed ID: 9092145
    [Abstract] [Full Text] [Related]

  • 5. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
    Aliot E.
    Arch Mal Coeur Vaiss; 1996 Aug 10; 89 Spec No 3():23-31. PubMed ID: 8949315
    [Abstract] [Full Text] [Related]

  • 6. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
    Buch P, Rasmussen S, Abildstrom SZ, Køber L, Carlsen J, Torp-Pedersen C, TRACE investigators.
    Eur Heart J; 2005 Jan 10; 26(2):145-52. PubMed ID: 15618070
    [Abstract] [Full Text] [Related]

  • 7. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 10; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 9. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA, Survival and Ventricular Enlargement Trial.
    Am Heart J; 2004 Aug 27; 148(2):356-64. PubMed ID: 15309009
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 27; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J, Dzúrik R.
    Vnitr Lek; 1998 Jun 27; 44(6):326-31. PubMed ID: 9820054
    [Abstract] [Full Text] [Related]

  • 12. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
    Buksa M.
    Med Arh; 2000 Jun 27; 54(2):103-6. PubMed ID: 10934839
    [Abstract] [Full Text] [Related]

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 27; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK, Vidyasagar S, Adiga S, Naidu MU, Usha Rani P, Rao D, Bairy KL, Nair S, Jayaprakash B, Shashikiran U, Mukhyapranaprabhu.
    Indian J Physiol Pharmacol; 2006 Sep 27; 50(4):421-6. PubMed ID: 17402274
    [Abstract] [Full Text] [Related]

  • 15. Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
    Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G, Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-3 Investigators.
    Am Heart J; 2002 Dec 27; 144(6):1018-25. PubMed ID: 12486426
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr 27; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. Investigator Study Group.
    De Bruijn JH, Orofiamma BA, Pauly NC.
    J Cardiovasc Pharmacol; 1994 Apr 27; 23 Suppl 4():S60-4. PubMed ID: 7527104
    [Abstract] [Full Text] [Related]

  • 18. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F, McClaran J, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP.
    Clin Exp Hypertens A; 1989 Apr 27; 11 Suppl 2():587-603. PubMed ID: 2691131
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
    Torp-Pedersen C, Køber L, Carlsen J.
    Am Heart J; 1996 Jul 27; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 27; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.